Search

everythinglearnresearchcommunity

for

Search:↓

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Nonionic liposomes are the best for delivering genes to skin cells.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

There is no significant link between male pattern baldness and insulin resistance.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Modern science supports the use of some Ayurvedic plants for health, as ancient practices suggested.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.